Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
基於二鈉乙二胺四乙酸的螯合療法對於有心肌梗塞及糖尿病病史的患者:TACT2 隨機臨床試驗。
JAMA 2024-08-14
The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD).
慢性腎臟病患者血管鈣化的鎂補充效應:隨機臨床試驗(MAGiCAL-CKD)。
J Am Soc Nephrol 2023-08-20
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
協調照護以最佳化第二型糖尿病心血管預防治療:一項隨機臨床試驗。
JAMA 2024-02-07
Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK).
血液透析患者治療維生素K2對血管鈣化影響的隨機對照臨床試驗(Trevasc-HDK)。
Kidney Int Rep 2023-09-16
Influence of sodium thiosulfate on coronary artery calcification of patients on dialysis: a meta-analysis.
透析患者冠狀動脈鈣化之影響:硫代硫酸鈉的荟萃分析。
Ren Fail 2024-03-28
Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study.
2型糖尿病和血液透析患者循環系統事件的再發:來自4D研究的分析。
Clin Kidney J 2023-10-03
Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
傳統中醫複方(通心络)對急性心肌梗塞患者臨床結果的影響:CTS-AMI隨機臨床試驗。
JAMA 2023-11-01
A Randomized Trial of the IMPACT of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
接受透析治療患者中鐵檸檬酸鐵對促紅細胞生成素和靜脈注射鐵使用影響的隨機試驗。
Am J Nephrol 2024-07-07
Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials.
Colchicine 在有周邊動脈疾病的 Medicare 受益者中降低心血管和肢體風險:目標試驗的模擬。
Eur Heart J Open 2024-08-23
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the Tirzepatide treatment on coronary atherosclerosis progression: The (T-PLAQUE) randomized-controlled trial design: tirzepatide and plaque.
tirzepatide 對冠狀動脈動脈粥樣硬化進展的影響:使用 MDCT 的理由與設計:Tirzepatide 對冠狀動脈動脈粥樣硬化進展的隨機對照試驗設計:tirzepatide 與斑塊。
Am Heart J 2024-08-26
Invasive Treatment Strategy for Older Patients with Myocardial Infarction.
老年患者心肌梗塞的侵入性治療策略。
N Engl J Med 2024-09-03
最近一項針對75歲以上非ST段抬高心肌梗塞(NSTEMI)患者的研究,探討保守醫療與侵入性策略的效果。研究包含1518名患者,隨機分為侵入性組(753人)和保守組(765人),隨訪中位數為4.1年。結果顯示,兩組在心血管死亡或非致命性心肌梗塞的發生率上無顯著差異(侵入性組25.6% vs. 保守組26.3%)。雖然侵入性策略在減少非致命性心肌梗塞方面有潛在益處,但整體風險並未顯著降低,建議對於年長患者,保守策略同樣有效。
PubMedDOI